GlassScriptPhysician profile
Ziad Sayedahmad
NPI 1679987481
$15,249.40
in general payments reported to CMS, 2019-2025
36 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $179 · 2021: $1,153 · 2022: $10K · 2023: $1,624 · 2024: $955 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,123.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,104.82 | 2022-2024 | Onyx Frontier |
| Abiomed | $1,810.59 | 2019-2025 | Impella |
| Abbott Laboratories | $1,409.27 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $368.49 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $298.39 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $297.01 | 2022-2025 | Breztri, Brilinta, Farxiga |
| Merck Sharp & Dohme LLC | $285.29 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $262.64 | 2022-2024 | |
| Cardiovascular Systems INC. | $258.87 | 2019-2023 | Diamondback Coronary |
| Novo Nordisk INC | $235.04 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $205.50 | 2023-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.93 | 2023-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $136.78 | 2022 | |
| Livanova USA, INC. | $129.92 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Opsumit, Uptravi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $116.29 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $113.43 | 2023-2024 | Inpefa |
| Pfizer INC. | $105.88 | 2022-2024 | |
| Ge Healthcare | $100.21 | 2022 | |
| Medtronic Vascular, INC. | $85.79 | 2019 | |
| Terumo Medical Corporation | $85.53 | 2025 | Glidewire |
| Cleerly, INC. | $70.30 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Asahi Intecc USA, INC. | $69.70 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $56.55 | 2023 | Arcalyst |
| Cathworks, INC. | $44.96 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.75 | 2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $35.56 | 2023 | Hemosphere, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $28.11 | 2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $25.68 | 2023 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $24.92 | 2024 | Amvuttra |
| Biotronik INC. | $24.67 | 2025 | Acticor 7 Vr-T Dx |
| Lilly USA, LLC | $24.39 | 2024 | Mounjaro |
| Philips North America LLC | $22.79 | 2025 | Extended Holter |
| United Therapeutics Corporation | $18.16 | 2023 | Tyvaso |
| Lantheus Medical Imaging, INC. | $14.43 | 2019 | |
| Glaxosmithkline, LLC. | $13.76 | 2025 | Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Sayedahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.